Reslizumab in the treatment of inadequately controlled asthma in adults and adolescents with elevated blood eosinophils: clinical trial evidence and future prospects.
about
Bronchial thermoplasty and the role of airway smooth muscle: are we on the right direction?CRTH2 antagonists in asthma: current perspectives.Biologic agents for severe asthma patients: clinical perspectives and implications.Overexpression of miR-155-5p Inhibits the Proliferation and Migration of IL-13-Induced Human Bronchial Smooth Muscle Cells by Suppressing TGF-β-Activated Kinase 1/MAP3K7-Binding Protein 2.Severe, eosinophilic asthma in primary care in Canada: a longitudinal study of the clinical burden and economic impact based on linked electronic medical record data.The use of intravenous versus subcutaneous monoclonal antibodies in the treatment of severe asthma: a review
P2860
Reslizumab in the treatment of inadequately controlled asthma in adults and adolescents with elevated blood eosinophils: clinical trial evidence and future prospects.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Reslizumab in the treatment of ...... evidence and future prospects.
@en
type
label
Reslizumab in the treatment of ...... evidence and future prospects.
@en
prefLabel
Reslizumab in the treatment of ...... evidence and future prospects.
@en
P2860
P921
P356
P1476
Reslizumab in the treatment of ...... evidence and future prospects.
@en
P2093
Jorge Máspero
P2860
P304
P356
10.1177/1753465817717134
P577
2017-07-06T00:00:00Z
2017-08-01T00:00:00Z